Sinphar Pharmaceutical Co.,Ltd. (TPE:1734)

Sinphar Pharmaceutical Revenue

Sinphar Pharmaceutical had revenue of 871.15M TWD in the quarter ending June 30, 2026, with 7.16% growth. This brings the company's total for the last twelve months to 3.45B, up 7.08% year-over-year. In the year 2025, Sinphar Pharmaceutical had annual revenue of 3.37B with 7.00% growth. That makes Sinphar Pharmaceutical the 22,189th largest company in the world by revenue and 895th in Taiwan.

• Revenue (ttm): 3.45B
• Revenue Growth: +7.08%
• P/S Ratio: 1.80
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 6.21B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Efficacy Medication 2.07B 61.4%
• Functional Food 1.18B 35.1%
• Others 115.73M 3.4%

By Geography

Chart

• Taiwan 2.92B 86.7%
• Mainland China 209.24M 6.2%
• Others 90.25M 2.7%
• United States 59.40M 1.8%
• Indonesia 46.09M 1.4%
• Vietnam 43.49M 1.3%

Fiscal year ended Dec 31, 2025 See the full Sinphar Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.37B	220.69M	7.00%
Dec 31, 2024	3.15B	187.69M	6.33%
Dec 31, 2023	2.96B	106.28M	3.72%
Dec 31, 2022	2.86B	423.14M	17.39%
Dec 31, 2021	2.43B	45.06M	1.89%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 15, 2026

Data Sources Report a data error